-- Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/482052 .
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Major Points from Table of Content:
1 Table of Contents
2 Introduction
3 Therapeutics Development
4 Therapeutics Assessment
5 Companies Involved in Therapeutics Development
6 Dormant Projects
7 Discontinued Products
8 Product Development Milestones
9 Appendix
Browse the complete report @ Colorectal Cancer Drug Development Pipeline Review, 2017 .
Some Points from List of Figures:
Figure 1: Number of Products under Development for Anal Cancer 12
Figure 2: Number of Products under Development by Companies Anal Cancer 13
Figure 3: Number of Products under Development for Rectal Cancer 16
Figure 4: Number of Products under Development by Companies Rectal Cancer 17
Figure 5: Number of Products under Development for Colorectal Cancer 18
Figure 6: Number of Products under Development by Companies Colorectal Cancer 20
Figure 7: Number of Products under Development by Universities/Institutes Colorectal Cancer 30
Figure 8: Number of Products by Top 10 Targets Anal Cancer 56
Figure 9: Number of Products by Stage and Top 10 Targets Anal Cancer 56
Figure 10: Number of Products by Top 10 Mechanism of Actions Anal Cancer 58
……
Pneumonia Drug Development Pipeline Review, 2017
Companies Mentioned:
Achaogen Inc
Adenium Biotech ApS
Aridis Pharmaceuticals LLC
AstraZeneca Plc
Bayer AG
Biotest AG
Cardeas Pharma Corp
Destiny Pharma Ltd
Dong-A Socio Holdings Co Ltd
InflaRx GmbH
ioGenetics Inc
Kyorin Pharmaceutical Co Ltd
Lakewood-Amedex Inc
MedImmune LLC
Meiji Seika Pharma Co Ltd
Melinta Therapeutics Inc
Merck & Co Inc
Motif Bio Plc
Nabriva Therapeutics AG
Paratek Pharmaceuticals Inc
Polyphor Ltd
Sealife PHARMA GMBH
Shionogi & Co Ltd
TaiGen Biotechnology Co Ltd
Takeda Pharmaceutical Company Ltd
Tetraphase Pharmaceuticals Inc
The Medicines Company
Theravance Biopharma Inc
TiGenix NV
Wockhardt Ltd
Zavante Therapeutics Inc
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/482056 .
Scope
- Which companies are the most active within the pipeline for pneumonia therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of pneumonia?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Place a purchase order of this report @ http://www.orbisresearch.com/contact/purchase/482056 .
Some Points from Table of Content:
1 Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction
2.1 Pneumonia Report Coverage 8
2.2 Community Acquired Pneumonia - Overview 8
2.3 Hospital Acquired Pneumonia (HAP) - Overview 8
2.4 Ventilator Associated Pneumonia (VAP) - Overview 8
3 Therapeutics Development
3.1 Community Acquired Pneumonia 9
3.2 Hospital Acquired Pneumonia (HAP) 13
3.3 Ventilator Associated Pneumonia (VAP) 19
4 Therapeutics Assessment
4.1 Community Acquired Pneumonia 24
4.2 Hospital Acquired Pneumonia (HAP) 30
4.3 Ventilator Associated Pneumonia (VAP) 37
Some Points from List of Tables
Table 1: Number of Products under Development for Community Acquired Pneumonia 9
Table 2: Number of Products under Development by Companies Community Acquired Pneumonia 11
Table 3: Products under Development by Companies Community Acquired Pneumonia 12
Table 4: Number of Products under Development for Hospital Acquired Pneumonia (HAP) 13
Table 5: Number of Products under Development by Companies Hospital Acquired Pneumonia (HAP) 15
Table 6: Products under Development by Companies Hospital Acquired Pneumonia (HAP) 16
Table 7: Number of Products under Development for Ventilator Associated Pneumonia (VAP) 19
Table 8: Number of Products under Development by Companies Ventilator Associated Pneumonia (VAP) 21
Table 9: Products under Development by Companies Ventilator Associated Pneumonia (VAP) 22
Table 10: Number of Products by Stage and Target Community Acquired Pneumonia 25
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Website: http://www.orbisresearch.com/reports/index/colorectal-cancer-drug-development-pipeline-review-2017
Release ID: 257373
Google
RSS